Proteus Announces FDA Clearance of Wireless Personal Health Monitor

Company Also Completes Financing with Leading Medical Device, Pharmaceutical and Semiconductor Companies as Investors

REDWOOD CITY, Calif.--(HSMN NewsFeed)--Proteus Biomedical Inc., a pioneer in intelligent medicine, announced today that it has received 510(k) clearance from the US Food and Drug Administration to market its wireless personal health device, the Raisin Personal Monitor.

Proteus’ Raisin Personal Monitor is a miniaturized, wearable device for remote recording and analysis of heart rate, physical activity, body position and patient-logged events. This personalized physiologic information is then communicated via Bluetooth to any computerized device, such as a mobile phone for emerging mHealth applications. The monitor attaches to a patient’s skin with an adhesive layer and is worn like a Band-Aid®.

Full text >>